Gross profit · 2019–2025

Ascendis Pharma gross profit

$706M+104.4% · FY2025

Ascendis Pharma (ASND) reported $706M in gross profit for fiscal 2025, +104.4% year on year.

$15.0M2019$7.9M2020$5.0M2021$41.1M2022$240M2023$346M2024$706M2025
Ascendis Pharma — Gross profit, 2019–2025
Fiscal yearGross profitChangeFiling
FY20252025-12-31$706M+104.4%Open →
FY20242024-12-31$346M+43.8%Open →
FY20232023-12-31$240M+484.8%Open →
FY20222022-12-31$41.1M+716.8%Open →
FY20212021-12-31$5.0M−36.6%Open →
FY20202020-12-31$7.9M−47.0%Open →
FY20192019-12-31$15.0M—Open →

Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +90.1%

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

Gross profit at companies of similar size

Full ranking by gross profit →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Ascendis Pharma gross profit |url=https://companiesranked.com/en/company/ascendis-pharma/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Ascendis Pharma gross profit. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/gross-profit

BibTeX

@misc{companiesranked-en-company-ascendis-pharma-gross-profit-2026,
  author       = {{CompaniesRanked}},
  title        = {{Ascendis Pharma gross profit}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/gross-profit}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001193125-26-046590 · February 11, 2026

{{cite web |title=Ascendis Pharma gross profit — 20-F (0001193125-26-046590) |url=https://www.sec.gov/Archives/edgar/data/1612042/000119312526046590/asnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Ascendis Pharma overview